CARLISLE COMPANIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CARLISLE COMPANIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,675	4,090	4,480	4,485	3,970	3,837	5,449	4,587	5,004	5,020
Cost of revenue	2,339	2,703	3,305	3,179	2,833	2,741	3,583	2,953	3,116	3,227
Gross profit	1,157	1,048	1,175	1,372	1,137	1,096	1,866	1,634	1,888	1,793
Research and development	45.4	51.3	55.1	52.2	45.4	16.4	19	28.7	35.4	47.1
Selling, general and administrative	495	533	625	630	603	508	624	625	723	745
Operating income	404	464	509	634	488	573	1,205	983	1,143	1,003
Interest expense							85.9	75.6	73.3	78.5
Interest income		0.5	11.2	7.9	4.7	1.1	6.8	20.1	60.3	25.9
Other non-operating income	5.6	-1.5	-9.6	-0.9	-2.9	-4.4	-2	3.1	-19.2	-1.1
Pre-tax income	379	429	446	575	404	490	1,124	930	1,111	949
Income tax	148	88.4	87.3	117	78.5	104	266	212	246	206
Income from continuing operations	231	341	359	458	326	386	858	719	865	743
Net income	250	366	611	473	320	422	924	767	1,312	741
EBITDA	542	633	700	840	712	693	1,363	1,134	1,316	1,199
EPS, basic	3.86	5.75	10.09	8.28	5.85	8.01	17.80	15.35	28.17	17.27
EPS, diluted	3.82	5.71	10.02	8.19	5.80	7.91	17.56	15.18	27.82	17.12
Shares, basic (weighted)	64.2	63.1	60.4	56.9	54.5	52.5	51.8	49.9	46.5	42.8
Shares, diluted (weighted)	64.9	63.6	60.8	57.5	55	53.2	52.5	50.4	47.1	43.2
Dividend per share	1.30	1.44	1.54	1.80	2.05	2.13	2.58	3.20	3.70	4.20

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	385	378	804	351	897	324	365	577	754	1,112
Receivables	512	626	698	683	554	815	615	615	580	594
Inventory	377	449	458	511	433	605	518	362	473	447
Other current assets	57	73.6	75.3	76.7	60.2	285	125	108	93.5	95.7
Total current assets	1,355	1,645	2,057	1,752	2,209	2,151	2,245	3,408	1,926	2,277
Property, plant and equipment	632	731	760	784	672	760	602	655	712	807
Lease right-of-use assets				78	68.3	81.4	51.1	50.4	122	130
Goodwill	1,021	1,452	1,442	1,620	1,642	1,173	1,178	1,203	1,478	1,539
Intangible assets	872	1,065	968	1,141	961	2,009	1,328	1,253	1,505	1,426
Other non-current assets	25	34.9	22.9	104	107	128	97.9	101	196	214
Total assets	3,966	5,300	5,249	5,496	5,866	7,247	7,222	6,620	5,817	6,263
Accounts payable	244	332	312	327	285	432	274	246	261	233
Accrued liabilities	247	258	258	295	275	351	290	293	405	503
Deferred revenue	23.2	27.8	25.5	27	32.5	33.9	24.4	26.4	28.3
Short-term debt	0	0	0	250	1.1	352	302	403	3.2	4.8
Total current liabilities	514	659	596	899	646	1,170	1,078	1,186	666	736
Long-term debt	596	1,586	1,588	1,341	2,080	2,575	2,281	1,887	1,887	2,882
Lease liabilities				61.8	53.1	64.4	40.4	34.8	101	105
Other non-current liabilities	217	289	267	392	345	622	474	420	250	262
Total liabilities	1,499	2,772	2,652	2,853	3,329	4,617	4,198	3,791	3,353	4,468
Total debt	596	1,586	1,588	1,592	2,081	2,927	2,583	2,289	1,891	2,886
Paid-in capital	335	354	384	417	442	482	513	554	589	604
Retained earnings	2,547	2,821	3,351	3,721	3,929	4,238	5,027	5,634	6,773	7,333
Treasury stock	-383	-650	-1,102	-1,450	-1,814	-2,063	-2,436	-3,326	-4,867	-6,149
Other comprehensive income	-122	-85.7	-122	-124	-97	-105	-158	-111	-110	-70
Shareholders' equity	2,467	2,528	2,597	2,643	2,538	2,630	3,024	2,829	2,463	1,795
Total equity	2,467	2,528	2,597	2,643	2,538	2,630	3,024	2,829	2,463	1,795
Total liabilities and equity	3,966	5,300	5,249	5,496	5,866	7,247	7,222	6,620	5,817	6,263
Shares outstanding	64.3	61.8	58	55.7	52.9	52	50.9	47.7	44.4	41

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	250	366	611	473	320	422	924	767	1,312	741
Depreciation and amortization	138	169	191	205	224	120	159	151	173	197
Stock-based compensation	-2.6	13.2	23.9	26.1	29.9	19.4	31.2	41.5	30.1	34.8
Deferred income tax	-25.5	-56.5	-0.6	-8.9	-26.1	-2.9	-22.8	-28.2	-59.1	9.8
Change in receivables	0.3	-53.9	-32.6	1	78.9	-207	-25.9	1.5	69.6	-3.4
Change in inventory	-12.2	-48.5	-29	-1.9	16.4	-137	-165	158	-104	33.2
Change in payables	21.6	42.7	-39.5	16.5	-15.2	85.4	-60.5	-27	-4.1	-33
Cash from operations	531	459	339	703	697	422	1,001	1,201	1,030	1,102
Capital expenditures	-109	-160	-121	-88.9	-95.5	-135	-184	-142	-113	-131
Acquisitions	-186	-934	-19.5	-616	-35.4	-1,571	-24.7	-36.1	-677	-110
Purchases of investments				0	0	-30.2
Sales and maturities of investments							10.3	1.1	20.8
Cash from investing	-293	-1,094	629	-695	-123	-1,486	-61.1	352	1,230	-240
Debt issued	0	997	0	0	741	843	0	0	0	988
Debt repaid	-150	0	0	0	-259	0	-350	-300	-400	0
Stock issued	48.4					85.9	40.4	25.7	80.2	23.5
Share buybacks	-75	-268	-460	-382	-382	-316	-400	-900	-1,586	-1,300
Dividends paid	-84.5	-92.1	-93.5	-103	-112	-113	-134	-160	-172	-181
Cash from financing	-261	627	-541	-461	-24.7	488	-862	-1,350	-2,110	-504
Exchange rate effect	-2.1	2.7	-1.1	0.6	1.6	-1.2	-2.2	1.5	-1.7	0.9
Net change in cash	-25.4	-5.7	427	-452	551	-578	75.6	206	148	359
Free cash flow	422	299	219	614	601	287	817	1,059	917	971
Interest paid	35.9	29.6	65.4	63.7	66.2	71.9	82.9	71.9	70.2	56.2
Income taxes paid	192	143	203	113	117	133	296	248	324	206

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $326.37 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	35.3%	Gross profit / revenue.
Operating margin	19.9%	Operating income / revenue.
EBITDA margin	23.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	18.6%	Pre-tax income / revenue.
Net margin	14.2%	Net income / revenue.
FCF margin	17.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	19.8%	Cash from operations / revenue.
Effective tax rate	22.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	44.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.6%	Net income / average total assets.
Return on invested capital (ROIC)	20.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	1.0%	Research and development expense / revenue.
SG&A / revenue	14.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.8%	Capital expenditures / revenue.
D&A / revenue	3.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-2.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-12.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-5.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	15.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-8.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-4.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	11.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-43.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-7.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	18.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-38.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-0.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	24.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	6.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	3.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	9.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	5.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	5.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	10.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	13.5%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	17.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	15.4%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-27.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-16.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-6.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	7.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	1.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-8.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-6.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-4.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.60x	Current assets / current liabilities.
Quick ratio	1.84x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.75x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.79x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	46.4%	Total debt / total assets.
Liabilities / assets	74.1%	Total liabilities / total assets.
Net debt	$2.22B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.83x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	9.71x	Operating income / interest expense.
Working capital	$1.41B	Current assets - current liabilities.
Goodwill and intangibles / assets	46.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.29B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.82x	Revenue / average total assets.
Fixed asset turnover	6.16x	Revenue / average property, plant and equipment.
Inventory turnover	6.70x	Cost of revenue / average inventory.
Days inventory	55 days	365 x average inventory / cost of revenue.
Receivables turnover	5.33x	Revenue / average receivables.
Days sales outstanding	68 days	365 x average receivables / revenue.
Days payables	45 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	78 days	Days inventory + days sales outstanding - days payables.
FCF conversion	119.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	14.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$17.89	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$125.85	Revenue / diluted weighted shares.
FCF per share	$21.40	Free cash flow / diluted weighted shares.
Operating cash flow per share	$24.94	Cash from operations / diluted weighted shares.
Book value per share	$40.63	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$32.30	Tangible book value / shares outstanding.
Cash per share	$16.72	(Cash + short-term investments) / shares outstanding.
Payout ratio	25.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	21.1%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	126.9%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$12.96B	Share price x shares outstanding.
Enterprise value	$15.19B	Market cap + total debt - cash - short-term investments.
P/E	17.9x	Market cap / net income. Only when net income is positive.
P/S	2.54x	Market cap / revenue.
P/B	8.01x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	15.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	12.8x	Market cap / cash from operations, when positive.
EV/Sales	2.98x	Enterprise value / revenue.
EV/EBIT	14.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	12.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	17.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.7%	Free cash flow / market cap.
Earnings yield	5.6%	Net income / market cap (the inverse of P/E).
Dividend yield	1.4%	Dividends paid over the period / market cap.
Shareholder yield	9.9%	(Dividends paid + share buybacks) / market cap.

What was CARLISLE COMPANIES INC's revenue in fiscal 2025?

CARLISLE COMPANIES INC reported revenue of $5.02B for fiscal 2025, 0.3% higher than the year before.

Was CARLISLE COMPANIES INC profitable in fiscal 2025?

Yes. Net income was $740.7M, a net margin of 14.8%.

How much free cash flow did CARLISLE COMPANIES INC generate in fiscal 2025?

Cash from operations of $1.10B minus capital expenditures of $131.2M left free cash flow of $970.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CARLISLE COMPANIES INC